Of the 785 patients with breast cancer, 171 cases were triple-negative type, 98 cases were Luminal B HER2-positive type, 325 cases were Luminal B HER2-negative type, 62 cases were Luminal A type, and 129 cases were HER2-overexpressing type. This evidence concerns the gene ERBB2 and breast cancer.